Alterity Therapeutics Ltd.ASX: ATH

European Orphan Designation granted for PBT434 for MSA

Jan 14, 2020 at 1:44 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd. has released a press release.

View Attachment